A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy

被引:35
作者
Felbor, U
Stohr, H
Amann, T
Schonherr, U
ApfelstedtSylla, E
Weber, BHF
机构
[1] UNIV WURZBURG,BIOZENTRUM,INST HUMANGENET,D-97074 WURZBURG,GERMANY
[2] UNIV ERLANGEN NURNBERG,AUGENKLIN & POLIKLIN,D-91054 ERLANGEN,GERMANY
[3] UNIV TUBINGEN,AUGENKLIN,ABT 2,D-72076 TUBINGEN,GERMANY
关键词
Sorsby's fundus dystrophy; mutational analysis; tissue inhibitor of metalloproteinases-3 (TIMP3);
D O I
10.1136/jmg.33.3.233
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Sorsby's fundus dystrophy (SFD) is a rare autosomal dominant macular disorder with age of onset usually in the fourth decade. It is characterised by loss of central vision owing to subretinal neovascularisation and disciform macular degeneration. In an effort to identify the SFD gene, the disease locus was first mapped to chromosome 22q13-qter by genetic linkage analysis, the same chromosomal region as the gene encoding the tissue inhibitor of metalloproteinases-3 (TIMP3). Subsequently, two separate mutations in TIMP3 were found in affected members of two unrelated SFD pedigrees (Tyr168Cys and Ser181Cys). More recently, two additional SFD related mutations, Ser156Cys and Gly167Cys, have provided further confirmation that heterozygous mutations in TIMP3 are causally responsible for the SFD phenotype. We now report the occurrence of the Tyr168Cys mutation in an SFD patient of Austrian descent and show that this mutation found earlier in an American SFD family arose independently. The new findings add to an emerging pattern of SFD mutations which all seem to affect the C-terminal region of the mature TIMP3 protein. In addition, all known mutations cause a change of an amino acid to a cysteine residue. This suggests a critical role for the additional C-terminal free thiol group in SFD pathogenesis.
引用
收藏
页码:233 / 236
页数:4
相关论文
共 20 条
  • [1] CLONING OF THE CDNA-ENCODING HUMAN TISSUE INHIBITOR OF METALLOPROTEINASES-3 (TIMP-3) AND MAPPING OF THE TIMP3 GENE TO CHROMOSOME-22
    APTE, SS
    MATTEI, MG
    OLSEN, BR
    [J]. GENOMICS, 1994, 19 (01) : 86 - 90
  • [2] CAPON MRC, 1989, OPHTHALMOLOGY, V96, P1769
  • [3] CHARACTERIZATION OF THE FUNCTIONAL DOMAIN OF TISSUE INHIBITOR OF METALLOPROTEINASES-2 (TIMP-2)
    DECLERCK, YA
    YEAN, TD
    LEE, Y
    TOMICH, JM
    LANGLEY, KE
    [J]. BIOCHEMICAL JOURNAL, 1993, 289 : 65 - 69
  • [4] A NOVEL SER156CYS MUTATION IN THE TISSUE INHIBITOR OF METALLOPROTEINASES-3 (TIMP3) IN SORSBYS FUNDUS DYSTROPHY WITH UNUSUAL CLINICAL-FEATURES
    FELBOR, U
    STOHR, H
    AMANN, T
    SCHONHERR, U
    WEBER, BHF
    [J]. HUMAN MOLECULAR GENETICS, 1995, 4 (12) : 2415 - 2416
  • [5] NIGHT BLINDNESS IN SORSBYS-FUNDUS-DYSTROPHY REVERSED BY VITAMIN-A
    JACOBSON, SG
    CIDECIYAN, AV
    REGUNATH, G
    RODRIGUEZ, FJ
    VANDENBURGH, K
    SHEFFIELD, VC
    STONE, EM
    [J]. NATURE GENETICS, 1995, 11 (01) : 27 - 32
  • [6] KLEIN R, 1992, OPHTHALMOLOGY, V99, P933
  • [7] LECO KJ, 1994, J BIOL CHEM, V269, P9352
  • [8] METALLOPROTEINASES AND THEIR INHIBITORS IN MATRIX REMODELING
    MATRISIAN, LM
    [J]. TRENDS IN GENETICS, 1990, 6 (04) : 121 - 125
  • [9] THE N-TERMINAL DOMAIN OF TISSUE INHIBITOR OF METALLOPROTEINASES RETAINS METALLOPROTEINASE INHIBITORY ACTIVITY
    MURPHY, G
    HOUBRECHTS, A
    COCKETT, MI
    WILLIAMSON, RA
    OSHEA, M
    DOCHERTY, AJP
    [J]. BIOCHEMISTRY, 1991, 30 (33) : 8097 - 8101
  • [10] DIFFERENT DOMAIN INTERACTIONS ARE INVOLVED IN THE BINDING OF TISSUE INHIBITORS OF METALLOPROTEINASES TO STROMELYSIN-1 AND GELATINASE-A
    NGUYEN, Q
    WILLENBROCK, F
    COCKETT, MI
    OSHEA, M
    DOCHERTY, AJP
    MURPHY, G
    [J]. BIOCHEMISTRY, 1994, 33 (08) : 2089 - 2095